HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of recombinant granulocyte colony-stimulating factor on blood neutrophil concentrations among patients with "idiopathic neonatal neutropenia": a randomized, placebo-controlled trial.

AbstractOBJECTIVES:
We previously described a severe, prolonged, idiopathic, but self-resolving, variety of neutropenia among preterm neonates. In the present study, we sought to assess the marrow neutrophil reserves of these patients by serially measuring blood neutrophils following the administration of recombinant granulocyte colony-stimulating factor (rG-CSF) or placebo.
STUDY DESIGN:
Prospective, randomized trial of rG-CSF vs placebo for infants with "idiopathic neonatal neutropenia".
RESULTS:
During 36 consecutive months, 2407 neonates were admitted to the neonatal intensive care unit; 429 weighed less than 1500 g at birth, 14 of these were later diagnosed with "idiopathic neonatal neutropenia"; 10 were enrolled in this trial. The five rG-CSF recipients had an immediate, marked increase in blood neutrophil concentration, indicating adequate rG-CSF-mobilizable marrow neutrophil reserves. This effect persisted to day 5, but counts were not different from those of the five placebo recipients on days 12 and 15.
CONCLUSIONS:
Patients with "idiopathic neonatal neutropenia" have a substantial rG-CSF-mobilizable marrow neutrophil reserve. On that basis, we speculate that this variety of neonatal neutropenia does not constitute a significant deficiency in antibacterial defense.
AuthorsSandra E Juul, Robert D Christensen
JournalJournal of perinatology : official journal of the California Perinatal Association (J Perinatol) Vol. 23 Issue 6 Pg. 493-7 (Sep 2003) ISSN: 0743-8346 [Print] United States
PMID13679938 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
Topics
  • Female
  • Granulocyte Colony-Stimulating Factor (therapeutic use)
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases (drug therapy)
  • Infant, Very Low Birth Weight
  • Leukocyte Count
  • Male
  • Neutropenia (drug therapy)
  • Neutrophils (drug effects)
  • Prospective Studies
  • Recombinant Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: